Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
  • A61K8/11—Encapsulated compositions
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
  • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
  • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K9/4816—Wall or shell material
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
  • A61Q19/10—Washing or bathing preparations

Definitions

• This invention relates to polymeric films which are suitable for forming shells or capsules for containing various non-aqueous liquids or solids.
• capsules are usually made from gelatin. However there are various reasons why it is sometimes undesirable to use a naturally occuring material such as gelatin, for instance because of its variable quality or because of a public preference to use a synthetic material rather than an animal-based material. It is known to form capsules from single homopolymeric materials such as polyvinyl alcohol. However, it is difficult with these polymeric compositions to produce a product having all the desired properties for each alternative use.
• the walls of gel capsules must have high mechanical strength and stability, and resistance to the substance which will be contained in the capsule shell. It is often necessary that the capsule shells should dissolve rapidly in water.
• the solubility properties can vary considerably from one requirement to another, for example the temperature of the aqueous solution in which the shell must dissolve may vary considerably. For example if capsules are filled with pesticides or herbicides the capsule walls must dissolve in cold water, so that the pesticide may be readily diluted for application to the land, whereas when the contained substance is bath oil, rapid solubility must be achieved for warm water.
• the gel capsule must be aesthetically acceptable and therefore it is beneficial if the film-forming polymeric material can be dyed and/or can be mixed with pearling agents.
• This invention relates to a film-forming polymeric system suitable for preparing capsule shells which can be varied easily according to the particular requirements of the filling material and , especially, to a system that is flexible, non-sticky and completely water soluble.
• a polymeric composition suitable for forming a capsule shell for containing a substantially non-aqueous substance characterised in that the composition comprises a water soluble synthetic film-forming polymeric composition of cationic and anionic moieties.
• the invention also provides a capsule shell in which at least part of the shell is formed from such a composition.
• the total capsule may be formed from two shells and at least one, and preferably both, of the shells are formed of the composition.
• a shell may be formed of two parts, one part being formed of the defined composition and the other part being formed from some other capsule-forming material.
• the invention also provides filled capsules in which at least part of the capsule shell, and preferably all the capsule shell, is formed from the composition.
• the synthetic film forming polymeric composition can comprise an amphoteric polymer formed by co-polymerisation of anionic ethylenically unsaturated monomer with cationic ethylenically unsaturated monomer and, optionally, nonionic ethylenically unsaturated monomer.
• the cationic and anionic moieties in the polymeric composition are provided by a blend of cationic polymer and anionic polymer, wherein each polymer is water soluble and film forming.
• Each polymer is generally formed by polymerisation of a monomer or monomer blend having the desired ionic character (anionic or cationic). If a blend is used, it may be a blend of ionic monomers of the chosen character or a blend with a non-ionic monomer.
• Each monomer or monomer blend is usually water-soluble in order to ensure that the polymer is soluble in water.
• the preferred cationic monomer is diallyldimethyl ammonium chloride or other diallyl dialkyl ammonium salt.
• Other suitable cationic monomers include dialkylaminoalkyl(meth)acrylate or -(meth)acrylamide, either as acid salts or, preferably, quaternary ammonium salts, the alkyl groups may each contain 1 to 4 carbon atoms and the aminoalkyl group may contain 1 to 8 carbon atoms.
• dialkylaminoethyl (meth)acrylates d i a I k y l a m i n om e t h y l (meth)acrylamides and dialkylamino-1,3-propyl (meth)acrylamides.
• These monomers may be present as acid salts or, prefeably, quaternary ammonium salts.
• the dialkyl group is generally dimethyl, e.g., (meth)acrylamideopropyl trimethyl ammonium chloride.
• the cationic monomers may be homopolymerised or copolymerised with each other or with a non-ionic monomer, preferably (meth)acrylamide to give a polymer formed of cationic moieties optionally with non-ionic moieties.
• the cationic polymers are usually formed from 30 to 100% by weight cationic monomer with the balance being non-ionic.
• the amount of cationic monomer is usually at least 50% and often at least 80% by weight and most preferably 100%.
• Other suitable cationic polymers are polyethylene imines and polyamines, e.g., polyamine epichlorhydrin polymers.
• the molecular weight of the cationic polymer should preferably be such that the polymer has intrinsic viscosity of at least 0.1, and preferably at least 0.3 dl/g (measured by suspended level viscometer at 25°C in molar aqueous sodium chloride).
• IV can be up to, for instance, 10dl/g or higher but is generally below 7, most usually below 4 and preferably below 2.5dl/g.
• Preferred values, especially for polymers of diallyl dimethyl ammonium chloride are in the range 0.8 to 2.4 dl/g. Such values indicate that preferred molecular weights in the region of around 50,000 to 1,000,000 or 2,000,000 and are preferably above 200,000. If the molecular weight is too high, the forming composition may have an unacceptably high viscosity at reasonable concentrations of polymer.
• anionic monomers that can be used in the invention include acrylic acid, methacrylic acid, maleic acid, 2-acrylamido-2- methyl propane sulphonic acid (AMPS), sodium vinyl sulphonate, or other ethylenically unsaturated carboxylic or sulphonic acids, often as alkali or other water soluble salts.
• AMPS 2-acrylamido-2- methyl propane sulphonic acid
• sodium vinyl sulphonate or other ethylenically unsaturated carboxylic or sulphonic acids, often as alkali or other water soluble salts.
• anionic monomers may be copolymerised with each other or with non-ionic monomer such as (meth) acrylamide.
• the proportions of anionic and nonionic monomer and molecular weights for the anionic polymers may all be similar to those discussed above for the cationic monomers, although it can be desirable for the molecular weight to be a little higher, for instance 500,000 to 10 million, preferably 1 million to 5 million.
• the molecular weight may be as discussed above for cationic polymers.
• the amount of non-ionic monomer in the blend is generally 0 to 50%, preferably 0 to 20%, by weight of the total monomer blend.
• the polymers must be totally soluble in water. Accordingly, the polymers are preferably linear homopolymers or copolymers of monoethylenically unsaturated water soluble monomers. However, cationic polymers which have a small degree, of cross-linking or branching, or that are formed from monomers that include a small proportion of insoluble monomer, can also be suitable provided they do not significantly affect solubility.
• compositions formed from either ionic type alone do not have satisfactory properties for water soluble capsules but the use of a blend of ionic types, and preferably the use of a blend of counterionic polymers, gives the opportunity of obtaining a variety of properties that can be selected according to selection of the ratio of cationic and anionic moieties.
• polymers of polyvinyl pyrrolidone or polyacrylamide or homopolymers of the anionic moieties described above tend to be too brittle when exposed to ambient humid atmospheres.
• Polymers of polyvinyl alcohol or homopolymers of the cationic moieties described above tend to have adequate flexibility but to be too sticky when exposed to ambient humid atmospheres. This problem of deliquescence applies also to some of the anionic polymers, and is particularly serious in respect of capsules of, for instance, cosmetic preparations such as bath oils.
• the anionic and cationic monomers i.e., moieties
• the molar ratio cationic: anionic moieties is preferably about 5:1 to 1:1, most preferably about 4:1 to 2:1.
• the weight ratio cationic:anionic monomers is generally at least 1:1 and can be up to 8:1, but 4:1 is often sufficient.
• a preferred range is 1.5:1 to 3:1, with best results generally at around 2:1.
• diallyl dimethyl ammonium chloride preferably as a homopolymer
• the anionic polymer is based on sodium acrylate or methacrylate (generally as homopolymer) typically having molecular weight in the range 10,000 to 5,000,000, preferably around 50,000 to 2,000,000.
• the shell-forming composition of the invention generally contains the defined synthetic polymer or polymer blend as the only film forming components.
• the composition is normally free of natural polymers such as gelatin.
• An advantage of the invention is that the film can be formulated wholly from reproducible synthetic polymers. Another advantage is that it can be formulated to dissolve rapidly and completely, without leaving a scum in the water in which it is dissolved.
• Another advantage of the invention is that the films can be heated, for instance during drying or formation of the capsules, without adversely affecting the properties of the film. This is in contrast to gelatin since that is liable to become brittle if it is heated significantly.
• the capsule shell can be used to contain a variety of substantially anhydrous fillings.
• the filling must be substantially anhydrous otherwise the water in it may weaken the shell and may even result in rupture of the shell.
• the water content of the filling is, initially, below 10% and preferably below 5% and, in particular, the total amount of water that is introduced by the filling must be such that the resultant moisture of the film is sufficiently low, generally below 30%, preferably below 20% and most preferably below 10% even when exposed to an ambient atmosphere.
• An advantage of the invention is that the film can easily be formulated to maintain structural integrity even when it does contain these small amounts of moisture.
• the filling for the capsule can be liquid or powder and can be for instance selected from for instance detergents, fabric softeners, fragrances, flavour oils, hazardous chemicals such as pesticides, herbicides or other agrochemicals, pharmaceuticals or cosmetics. It is particularly preferred that the filling is a cosmetic, in particular bath oil or bath grains. If the filling is a solid, it will be in particulate form which, can, typically, be such small particle size that, if it, was not encapsulat d might create a dusting hazard.
• a shell is pared that is suitable for forming a capsule for containing a non-aqueous bath additive such as bath oil or bath grains characterised in that the capsule comprises a water-soluble synthetic film-forming polymeric composition of cationic and anionic moieties in which the cationic moieties are provided by a cationic polymer and the anionic moieties are provided by an anionic polymer and the weight ratio of cationic to anionic polymer is from 1:1 to 8:1, preferably from 1.5:1 to 3:1, and most preferably around 2:1.
• the preferred polymers are polydiallyl dimethyl ammonium chloride and sodium polyacrylate or methacrylate, having the preferred molecular weights indicated above.
• the shell capsules may be of any size depending on the requirement of the particular use.
• the capsules must be small enough for swallowing and may therefore be below 1cm diameter, even below 0.5 cm diameter.
• the capsules Preferably have a diameter above 0.2cm, less preferably they could be microcapsules.
• slightly larger capsules such as those having diameter of from 1cm to 5cm may be preferred.
• compositions can contain, for instance, dyes and/or pearling agents.
• polymeric films suitable for making capsules were formed from various polymer solutions by drying, and the resulting films were evaluated for characteristics of appearance and stability of films, water-solubilities at temperatures of from 35-45oC, mechanical strength, and resistance to non-aqueous oils. The results are given in Tables 1 and 2 .
• PolyDADMAC having molecular weight around IV2 gives a tough opaque flexible film that is very sticky in humid atmospheres, whilst polyDADMAC having lower molecular weight forms a weaker film, that is again sticky in humid atmospheres.
• Polyacrylic acid (as the free acid) of molecular weight of around 2,000,000 gives a hard brittle film that is slightly sticky in a humid atmosphere whilst its sodium salt gives a brittle film that is slightly less sticky in humid atmospheres.
• Polyacrylamide gives an inflexible clear film.
• Mixtures of two or three parts by weight polyDADMAC with one part by weight sodium acrylate or methacrylate homopolymer give flexible opaque films that are only slightly sticky when wet and which dissolve rapidly and fully in warm water. When the film is formed from two parts polyDADMAC and one part polyacrylic acid homopolymer (as free acid) the film is rather brittle.
• Capsules may be formed for instance from the exemplified polymer compositions or other compositions of the invention by conventional capsule forming methods, including sachet folding or casting.
• the polymer solution may be cast into semi-spherical shapes and this is followed by sealing two semi-spheres together, for example using aqueous based adhesive or by moistening the edges of the semi-spherical shells and sealing them together by drying.
• Capsules can also be prepared by having for example a semi-sphere of water-soluble shell adhered to a non water-insoluble hemisphere.
• the capsules do not have to be entirely water-soluble, but may comprise a wall which is partly formed of the water-soluble synthetic film-forming polymeric composition according to the invention.
• the non-aqueous filling can be filled inside the shell capsules by known techniques, for instance injection into a fully formed, sealed shell capsule or by incorporation into the capsule during casting or other manufacturing step.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Epidemiology (AREA)
• Birds (AREA)
• Dermatology (AREA)
• Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Manufacturing Of Micro-Capsules (AREA)
• Cosmetics (AREA)
• Medicinal Preparation (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=10677626

Family Applications (1)

Country Status (4)

Cited By (1)

Families Citing this family (8)

Family Cites Families (5)

• 1990
  • 1990-06-14 GB GB909013307A patent/GB9013307D0/en active Pending
• 1991
  • 1991-06-11 WO PCT/GB1991/000930 patent/WO1991019487A1/en not_active Application Discontinuation
  • 1991-06-11 EP EP19910911159 patent/EP0533776A1/de not_active Withdrawn
  • 1991-06-11 CA CA002087273A patent/CA2087273A1/en not_active Abandoned

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events